APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brain and Central Nervous System Cancer Treatments

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Brain and Central Nervous System Cancer Treatments Market Analysis and Forecast 2026-2032

29 December 2025211 pages

Choose your research edition.

Industry ResearchBrain and Central Nervous System Cancer Treatments Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Brain and Central Nervous System Cancer Treatments Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Brain and Central Nervous System Cancer Treatments Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brain and Central Nervous System Cancer Treatments Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Brain and Central Nervous System Cancer Treatments Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Brain and Central Nervous System Cancer Treatments market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Brain and Central Nervous System Cancer Treatments is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Brain and Central Nervous System Cancer Treatments is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Brain and Central Nervous System Cancer Treatments is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Brain and Central Nervous System Cancer Treatments is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Brain and Central Nervous System Cancer Treatments include Teva, Sanofi, Johnson & Johnson, Novartis, Merck & Co., Roche, Pfizer, Bayer and AbbVie, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Brain and Central Nervous System Cancer Treatments, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Brain and Central Nervous System Cancer Treatments, also provides the sales of main regions and countries. Of the upcoming market potential for Brain and Central Nervous System Cancer Treatments, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Brain and Central Nervous System Cancer Treatments sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Brain and Central Nervous System Cancer Treatments market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Brain and Central Nervous System Cancer Treatments sales, projected growth trends, production technology, application and end-user industry.

Brain and Central Nervous System Cancer Treatments Segment by Company

Teva

Sanofi

Johnson & Johnson

Novartis

Merck & Co.

Roche

Pfizer

Bayer

AbbVie

Takeda

Otsuka

Merck KGaA

Ipsen

Gilead Sciences

Eli Lilly

Eisai

Celgene

Bristol-Myers Squibb

Biogen Idec

AstraZeneca

Astellas

Amgen

Brain and Central Nervous System Cancer Treatments Segment by Type

Immunotherapy (Biologic Therapy)

Hormonal Therapy

Chemotherapy

Targeted Therapy

Others

Brain and Central Nervous System Cancer Treatments Segment by Application

Brain Cancer

Spinal Cord Cancer

Others

Brain and Central Nervous System Cancer Treatments Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain and Central Nervous System Cancer Treatments market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brain and Central Nervous System Cancer Treatments and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain and Central Nervous System Cancer Treatments.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Brain and Central Nervous System Cancer Treatments in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Brain and Central Nervous System Cancer Treatments manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brain and Central Nervous System Cancer Treatments sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Brain and Central Nervous System Cancer Treatments Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immunotherapy (Biologic Therapy) Major Manufacturers Table 3. Hormonal Therapy Major Manufacturers Table 4. Chemotherapy Major Manufacturers Table 5. Targeted Therapy Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Brain and Central Nervous System Cancer Treatments Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Brain Cancer Major Manufacturers Table 9. Spinal Cord Cancer Major Manufacturers Table 10. Others Major Manufacturers Table 11. Brain and Central Nervous System Cancer Treatments Industry Trends Table 12. Brain and Central Nervous System Cancer Treatments Industry Drivers Table 13. Brain and Central Nervous System Cancer Treatments Industry Opportunities and Challenges Table 14. Brain and Central Nervous System Cancer Treatments Industry Restraints Table 15. Global Brain and Central Nervous System Cancer Treatments Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Brain and Central Nervous System Cancer Treatments Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Brain and Central Nervous System Cancer Treatments Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Region (2021-2026) Table 19. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Region (2027-2032) Table 20. Global Brain and Central Nervous System Cancer Treatments Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Brain and Central Nervous System Cancer Treatments Sales by Region (2021-2026) & (K Units) Table 22. Global Brain and Central Nervous System Cancer Treatments Sales by Region (2027-2032) & (K Units) Table 23. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Region (2021-2026) Table 24. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Region (2027-2032) Table 25. Global Brain and Central Nervous System Cancer Treatments Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Brain and Central Nervous System Cancer Treatments Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Manufacturers (2021-2026) Table 29. Global Brain and Central Nervous System Cancer Treatments Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Brain and Central Nervous System Cancer Treatments Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Brain and Central Nervous System Cancer Treatments Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Brain and Central Nervous System Cancer Treatments Manufacturers, Product Type & Application Table 33. Global Brain and Central Nervous System Cancer Treatments Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Brain and Central Nervous System Cancer Treatments by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Brain and Central Nervous System Cancer Treatments Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Brain and Central Nervous System Cancer Treatments Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Type (2021-2026) Table 40. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Type (2027-2032) Table 41. Global Brain and Central Nervous System Cancer Treatments Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 43. Global Brain and Central Nervous System Cancer Treatments Sales by Type (2027-2032) & (K Units) Table 44. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026) Table 45. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2027-2032) Table 46. Global Brain and Central Nervous System Cancer Treatments Price by Type (2021-2026) & (US$/Unit) Table 47. Global Brain and Central Nervous System Cancer Treatments Price by Type (2027-2032) & (US$/Unit) Table 48. Global Brain and Central Nervous System Cancer Treatments Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Brain and Central Nervous System Cancer Treatments Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Application (2021-2026) Table 52. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Application (2027-2032) Table 53. Global Brain and Central Nervous System Cancer Treatments Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 55. Global Brain and Central Nervous System Cancer Treatments Sales by Application (2027-2032) & (K Units) Table 56. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Application (2021-2026) Table 57. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Application (2027-2032) Table 58. Global Brain and Central Nervous System Cancer Treatments Price by Application (2021-2026) & (US$/Unit) Table 59. Global Brain and Central Nervous System Cancer Treatments Price by Application (2027-2032) & (US$/Unit) Table 60. Teva Company Information Table 61. Teva Business Overview Table 62. Teva Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Teva Brain and Central Nervous System Cancer Treatments Product Portfolio Table 64. Teva Recent Development Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Sanofi Brain and Central Nervous System Cancer Treatments Product Portfolio Table 69. Sanofi Recent Development Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Johnson & Johnson Brain and Central Nervous System Cancer Treatments Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novartis Brain and Central Nervous System Cancer Treatments Product Portfolio Table 79. Novartis Recent Development Table 80. Merck & Co. Company Information Table 81. Merck & Co. Business Overview Table 82. Merck & Co. Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Merck & Co. Brain and Central Nervous System Cancer Treatments Product Portfolio Table 84. Merck & Co. Recent Development Table 85. Roche Company Information Table 86. Roche Business Overview Table 87. Roche Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Roche Brain and Central Nervous System Cancer Treatments Product Portfolio Table 89. Roche Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Pfizer Brain and Central Nervous System Cancer Treatments Product Portfolio Table 94. Pfizer Recent Development Table 95. Bayer Company Information Table 96. Bayer Business Overview Table 97. Bayer Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Bayer Brain and Central Nervous System Cancer Treatments Product Portfolio Table 99. Bayer Recent Development Table 100. AbbVie Company Information Table 101. AbbVie Business Overview Table 102. AbbVie Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. AbbVie Brain and Central Nervous System Cancer Treatments Product Portfolio Table 104. AbbVie Recent Development Table 105. Takeda Company Information Table 106. Takeda Business Overview Table 107. Takeda Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Takeda Brain and Central Nervous System Cancer Treatments Product Portfolio Table 109. Takeda Recent Development Table 110. Otsuka Company Information Table 111. Otsuka Business Overview Table 112. Otsuka Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Otsuka Brain and Central Nervous System Cancer Treatments Product Portfolio Table 114. Otsuka Recent Development Table 115. Merck KGaA Company Information Table 116. Merck KGaA Business Overview Table 117. Merck KGaA Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Merck KGaA Brain and Central Nervous System Cancer Treatments Product Portfolio Table 119. Merck KGaA Recent Development Table 120. Ipsen Company Information Table 121. Ipsen Business Overview Table 122. Ipsen Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Ipsen Brain and Central Nervous System Cancer Treatments Product Portfolio Table 124. Ipsen Recent Development Table 125. Gilead Sciences Company Information Table 126. Gilead Sciences Business Overview Table 127. Gilead Sciences Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Gilead Sciences Brain and Central Nervous System Cancer Treatments Product Portfolio Table 129. Gilead Sciences Recent Development Table 130. Eli Lilly Company Information Table 131. Eli Lilly Business Overview Table 132. Eli Lilly Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Eli Lilly Brain and Central Nervous System Cancer Treatments Product Portfolio Table 134. Eli Lilly Recent Development Table 135. Eisai Company Information Table 136. Eisai Business Overview Table 137. Eisai Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Eisai Brain and Central Nervous System Cancer Treatments Product Portfolio Table 139. Eisai Recent Development Table 140. Celgene Company Information Table 141. Celgene Business Overview Table 142. Celgene Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Celgene Brain and Central Nervous System Cancer Treatments Product Portfolio Table 144. Celgene Recent Development Table 145. Bristol-Myers Squibb Company Information Table 146. Bristol-Myers Squibb Business Overview Table 147. Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Product Portfolio Table 149. Bristol-Myers Squibb Recent Development Table 150. Biogen Idec Company Information Table 151. Biogen Idec Business Overview Table 152. Biogen Idec Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Biogen Idec Brain and Central Nervous System Cancer Treatments Product Portfolio Table 154. Biogen Idec Recent Development Table 155. AstraZeneca Company Information Table 156. AstraZeneca Business Overview Table 157. AstraZeneca Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. AstraZeneca Brain and Central Nervous System Cancer Treatments Product Portfolio Table 159. AstraZeneca Recent Development Table 160. Astellas Company Information Table 161. Astellas Business Overview Table 162. Astellas Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Astellas Brain and Central Nervous System Cancer Treatments Product Portfolio Table 164. Astellas Recent Development Table 165. Amgen Company Information Table 166. Amgen Business Overview Table 167. Amgen Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Amgen Brain and Central Nervous System Cancer Treatments Product Portfolio Table 169. Amgen Recent Development Table 170. North America Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2026) & (US$ Million) Table 171. North America Brain and Central Nervous System Cancer Treatments Revenue by Type (2027-2032) & (US$ Million) Table 172. North America Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 173. North America Brain and Central Nervous System Cancer Treatments Sales by Type (2027-2032) & (K Units) Table 174. North America Brain and Central Nervous System Cancer Treatments Sales Price by Type (2021-2026) & (US$/Unit) Table 175. North America Brain and Central Nervous System Cancer Treatments Sales Price by Type (2027-2032) & (US$/Unit) Table 176. North America Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2026) & (US$ Million) Table 177. North America Brain and Central Nervous System Cancer Treatments Revenue by Application (2027-2032) & (US$ Million) Table 178. North America Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 179. North America Brain and Central Nervous System Cancer Treatments Sales by Application (2027-2032) & (K Units) Table 180. North America Brain and Central Nervous System Cancer Treatments Sales Price by Application (2021-2026) & (US$/Unit) Table 181. North America Brain and Central Nervous System Cancer Treatments Sales Price by Application (2027-2032) & (US$/Unit) Table 182. North America Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. North America Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. North America Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. North America Brain and Central Nervous System Cancer Treatments Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. North America Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units) Table 187. North America Brain and Central Nervous System Cancer Treatments Sales by Country (2027-2032) & (K Units) Table 188. North America Brain and Central Nervous System Cancer Treatments Sales Price by Country (2021-2026) & (US$/Unit) Table 189. North America Brain and Central Nervous System Cancer Treatments Sales Price by Country (2027-2032) & (US$/Unit) Table 190. United States Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 191. Canada Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 192. Mexico Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 193. Europe Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2026) & (US$ Million) Table 194. Europe Brain and Central Nervous System Cancer Treatments Revenue by Type (2027-2032) & (US$ Million) Table 195. Europe Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 196. Europe Brain and Central Nervous System Cancer Treatments Sales by Type (2027-2032) & (K Units) Table 197. Europe Brain and Central Nervous System Cancer Treatments Sales Price by Type (2021-2026) & (US$/Unit) Table 198. Europe Brain and Central Nervous System Cancer Treatments Sales Price by Type (2027-2032) & (US$/Unit) Table 199. Europe Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2026) & (US$ Million) Table 200. Europe Brain and Central Nervous System Cancer Treatments Revenue by Application (2027-2032) & (US$ Million) Table 201. Europe Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 202. Europe Brain and Central Nervous System Cancer Treatments Sales by Application (2027-2032) & (K Units) Table 203. Europe Brain and Central Nervous System Cancer Treatments Sales Price by Application (2021-2026) & (US$/Unit) Table 204. Europe Brain and Central Nervous System Cancer Treatments Sales Price by Application (2027-2032) & (US$/Unit) Table 205. Europe Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. Europe Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. Europe Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. Europe Brain and Central Nervous System Cancer Treatments Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 209. Europe Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units) Table 210. Europe Brain and Central Nervous System Cancer Treatments Sales by Country (2027-2032) & (K Units) Table 211. Europe Brain and Central Nervous System Cancer Treatments Sales Price by Country (2021-2026) & (US$/Unit) Table 212. Europe Brain and Central Nervous System Cancer Treatments Sales Price by Country (2027-2032) & (US$/Unit) Table 213. Germany Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 214. France Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 215. U.K. Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 216. Italy Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 217. Russia Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 218. Spain Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 219. Netherlands Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 220. Switzerland Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 221. Sweden Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 222. Poland Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 223. China Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2026) & (US$ Million) Table 224. China Brain and Central Nervous System Cancer Treatments Revenue by Type (2027-2032) & (US$ Million) Table 225. China Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 226. China Brain and Central Nervous System Cancer Treatments Sales by Type (2027-2032) & (K Units) Table 227. China Brain and Central Nervous System Cancer Treatments Sales Price by Type (2021-2026) & (US$/Unit) Table 228. China Brain and Central Nervous System Cancer Treatments Sales Price by Type (2027-2032) & (US$/Unit) Table 229. China Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2026) & (US$ Million) Table 230. China Brain and Central Nervous System Cancer Treatments Revenue by Application (2027-2032) & (US$ Million) Table 231. China Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 232. China Brain and Central Nervous System Cancer Treatments Sales by Application (2027-2032) & (K Units) Table 233. China Brain and Central Nervous System Cancer Treatments Sales Price by Application (2021-2026) & (US$/Unit) Table 234. China Brain and Central Nervous System Cancer Treatments Sales Price by Application (2027-2032) & (US$/Unit) Table 235. Asia Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2026) & (US$ Million) Table 236. Asia Brain and Central Nervous System Cancer Treatments Revenue by Type (2027-2032) & (US$ Million) Table 237. Asia Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 238. Asia Brain and Central Nervous System Cancer Treatments Sales by Type (2027-2032) & (K Units) Table 239. Asia Brain and Central Nervous System Cancer Treatments Sales Price by Type (2021-2026) & (US$/Unit) Table 240. Asia Brain and Central Nervous System Cancer Treatments Sales Price by Type (2027-2032) & (US$/Unit) Table 241. Asia Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2026) & (US$ Million) Table 242. Asia Brain and Central Nervous System Cancer Treatments Revenue by Application (2027-2032) & (US$ Million) Table 243. Asia Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 244. Asia Brain and Central Nervous System Cancer Treatments Sales by Application (2027-2032) & (K Units) Table 245. Asia Brain and Central Nervous System Cancer Treatments Sales Price by Application (2021-2026) & (US$/Unit) Table 246. Asia Brain and Central Nervous System Cancer Treatments Sales Price by Application (2027-2032) & (US$/Unit) Table 247. Asia Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 248. Asia Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 249. Asia Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 250. Asia Brain and Central Nervous System Cancer Treatments Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 251. Asia Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units) Table 252. Asia Brain and Central Nervous System Cancer Treatments Sales by Country (2027-2032) & (K Units) Table 253. Asia Brain and Central Nervous System Cancer Treatments Sales Price by Country (2021-2026) & (US$/Unit) Table 254. Asia Brain and Central Nervous System Cancer Treatments Sales Price by Country (2027-2032) & (US$/Unit) Table 255. Japan Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 256. South Korea Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 257. India Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 258. Australia Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 259. Taiwan Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 260. Southeast Asia Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 261. SAMEA Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2026) & (US$ Million) Table 262. SAMEA Brain and Central Nervous System Cancer Treatments Revenue by Type (2027-2032) & (US$ Million) Table 263. SAMEA Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units) Table 264. SAMEA Brain and Central Nervous System Cancer Treatments Sales by Type (2027-2032) & (K Units) Table 265. SAMEA Brain and Central Nervous System Cancer Treatments Sales Price by Type (2021-2026) & (US$/Unit) Table 266. SAMEA Brain and Central Nervous System Cancer Treatments Sales Price by Type (2027-2032) & (US$/Unit) Table 267. SAMEA Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2026) & (US$ Million) Table 268. SAMEA Brain and Central Nervous System Cancer Treatments Revenue by Application (2027-2032) & (US$ Million) Table 269. SAMEA Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units) Table 270. SAMEA Brain and Central Nervous System Cancer Treatments Sales by Application (2027-2032) & (K Units) Table 271. SAMEA Brain and Central Nervous System Cancer Treatments Sales Price by Application (2021-2026) & (US$/Unit) Table 272. SAMEA Brain and Central Nervous System Cancer Treatments Sales Price by Application (2027-2032) & (US$/Unit) Table 273. SAMEA Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 274. SAMEA Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 275. SAMEA Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 276. SAMEA Brain and Central Nervous System Cancer Treatments Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 277. SAMEA Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units) Table 278. SAMEA Brain and Central Nervous System Cancer Treatments Sales by Country (2027-2032) & (K Units) Table 279. SAMEA Brain and Central Nervous System Cancer Treatments Sales Price by Country (2021-2026) & (US$/Unit) Table 280. SAMEA Brain and Central Nervous System Cancer Treatments Sales Price by Country (2027-2032) & (US$/Unit) Table 281. Brazil Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 282. Argentina Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 283. Chile Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 284. Colombia Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 285. Peru Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 286. Saudi Arabia Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 287. Israel Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 288. UAE Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 289. Turkey Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 290. Iran Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 291. Egypt Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Table 292. Key Raw Materials Table 293. Raw Materials Key Suppliers Table 294. Brain and Central Nervous System Cancer Treatments Distributors List Table 295. Brain and Central Nervous System Cancer Treatments Customers List Table 296. Research Programs/Design for This Report Table 297. Authors List of This Report Table 298. Secondary Sources Table 299. Primary Sources List of Figures Figure 1. Brain and Central Nervous System Cancer Treatments Image Figure 2. Global Brain and Central Nervous System Cancer Treatments Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brain and Central Nervous System Cancer Treatments Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immunotherapy (Biologic Therapy) Image Figure 5. Hormonal Therapy Image Figure 6. Chemotherapy Image Figure 7. Targeted Therapy Image Figure 8. Others Image Figure 9. Global Brain and Central Nervous System Cancer Treatments Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Brain and Central Nervous System Cancer Treatments Market Size Share 2021 VS 2025 VS 2032 Figure 11. Brain Cancer Image Figure 12. Spinal Cord Cancer Image Figure 13. Others Image Figure 14. Global Brain and Central Nervous System Cancer Treatments Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Brain and Central Nervous System Cancer Treatments Revenue (2021-2032) & (US$ Million) Figure 16. Global Brain and Central Nervous System Cancer Treatments Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Region (2021-2032) Figure 19. Global Brain and Central Nervous System Cancer Treatments Sales (2021-2032) & (K Units) Figure 20. Global Brain and Central Nervous System Cancer Treatments Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Brain and Central Nervous System Cancer Treatments Sales YoY (2021-2032) & (K Units) Figure 23. Europe Brain and Central Nervous System Cancer Treatments Sales YoY (2021-2032) & (K Units) Figure 24. China Brain and Central Nervous System Cancer Treatments Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Brain and Central Nervous System Cancer Treatments Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Brain and Central Nervous System Cancer Treatments Sales YoY (2021-2032) & (K Units) Figure 27. Global Brain and Central Nervous System Cancer Treatments Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Brain and Central Nervous System Cancer Treatments Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Fi

Scope & coverage.

Types
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Chemotherapy
  • Targeted Therapy
  • Others
Applications
  • Brain Cancer
  • Spinal Cord Cancer
  • Others
Companies covered
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck & Co.
  • Roche
  • Pfizer
  • Bayer
  • AbbVie
  • Takeda
  • Otsuka
  • Merck KGaA
  • Ipsen
  • Gilead Sciences
  • Eli Lilly
  • Eisai
  • Celgene
  • Bristol-Myers Squibb
  • Biogen Idec
  • AstraZeneca
  • Astellas
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Brain and Central Nervous System Cancer Treatments Market by Type
  3. 1.2.1 Global Brain and Central Nervous System Cancer Treatments Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immunotherapy (Biologic Therapy)
  5. 1.2.3 Hormonal Therapy
  6. 1.2.4 Chemotherapy
  7. 1.2.5 Targeted Therapy
  8. 1.2.6 Others
  9. 1.3 Brain and Central Nervous System Cancer Treatments Market by Application
  10. 1.3.1 Global Brain and Central Nervous System Cancer Treatments Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Brain Cancer
  12. 1.3.3 Spinal Cord Cancer
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Brain and Central Nervous System Cancer Treatments Market Dynamics
  1. 2.1 Brain and Central Nervous System Cancer Treatments Industry Trends
  2. 2.2 Brain and Central Nervous System Cancer Treatments Industry Drivers
  3. 2.3 Brain and Central Nervous System Cancer Treatments Industry Opportunities and Challenges
  4. 2.4 Brain and Central Nervous System Cancer Treatments Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Brain and Central Nervous System Cancer Treatments Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Brain and Central Nervous System Cancer Treatments Revenue by Region
  3. 3.2.1 Global Brain and Central Nervous System Cancer Treatments Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Brain and Central Nervous System Cancer Treatments Revenue by Region (2021-2026)
  5. 3.2.3 Global Brain and Central Nervous System Cancer Treatments Revenue by Region (2027-2032)
  6. 3.2.4 Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Brain and Central Nervous System Cancer Treatments Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Brain and Central Nervous System Cancer Treatments Sales by Region
  9. 3.4.1 Global Brain and Central Nervous System Cancer Treatments Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Brain and Central Nervous System Cancer Treatments Sales by Region (2021-2026)
  11. 3.4.3 Global Brain and Central Nervous System Cancer Treatments Sales by Region (2027-2032)
  12. 3.4.4 Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Brain and Central Nervous System Cancer Treatments Revenue by Manufacturers
  2. 4.1.1 Global Brain and Central Nervous System Cancer Treatments Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Brain and Central Nervous System Cancer Treatments Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Brain and Central Nervous System Cancer Treatments Sales by Manufacturers
  6. 4.2.1 Global Brain and Central Nervous System Cancer Treatments Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Brain and Central Nervous System Cancer Treatments Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Brain and Central Nervous System Cancer Treatments Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Brain and Central Nervous System Cancer Treatments Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Brain and Central Nervous System Cancer Treatments Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Brain and Central Nervous System Cancer Treatments Manufacturers, Product Type & Application
  13. 4.7 Global Brain and Central Nervous System Cancer Treatments Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Brain and Central Nervous System Cancer Treatments Market CR5 and HHI
  16. 4.8.2 2025 Brain and Central Nervous System Cancer Treatments Tier 1, Tier 2, and Tier 3
5 Brain and Central Nervous System Cancer Treatments Market by Type
  1. 5.1 Global Brain and Central Nervous System Cancer Treatments Revenue by Type
  2. 5.1.1 Global Brain and Central Nervous System Cancer Treatments Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Brain and Central Nervous System Cancer Treatments Sales by Type
  6. 5.2.1 Global Brain and Central Nervous System Cancer Treatments Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2032)
  9. 5.3 Global Brain and Central Nervous System Cancer Treatments Price by Type
6 Brain and Central Nervous System Cancer Treatments Market by Application
  1. 6.1 Global Brain and Central Nervous System Cancer Treatments Revenue by Application
  2. 6.1.1 Global Brain and Central Nervous System Cancer Treatments Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Brain and Central Nervous System Cancer Treatments Sales by Application
  6. 6.2.1 Global Brain and Central Nervous System Cancer Treatments Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Application (2021-2032)
  9. 6.3 Global Brain and Central Nervous System Cancer Treatments Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Brain and Central Nervous System Cancer Treatments Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Brain and Central Nervous System Cancer Treatments Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Brain and Central Nervous System Cancer Treatments Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Brain and Central Nervous System Cancer Treatments Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Merck & Co.
  26. 7.5.1 Merck & Co. Company Information
  27. 7.5.2 Merck & Co. Business Overview
  28. 7.5.3 Merck & Co. Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck & Co. Brain and Central Nervous System Cancer Treatments Product Portfolio
  30. 7.5.5 Merck & Co. Recent Developments
  31. 7.6 Roche
  32. 7.6.1 Roche Company Information
  33. 7.6.2 Roche Business Overview
  34. 7.6.3 Roche Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Roche Brain and Central Nervous System Cancer Treatments Product Portfolio
  36. 7.6.5 Roche Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Brain and Central Nervous System Cancer Treatments Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Bayer
  44. 7.8.1 Bayer Company Information
  45. 7.8.2 Bayer Business Overview
  46. 7.8.3 Bayer Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bayer Brain and Central Nervous System Cancer Treatments Product Portfolio
  48. 7.8.5 Bayer Recent Developments
  49. 7.9 AbbVie
  50. 7.9.1 AbbVie Company Information
  51. 7.9.2 AbbVie Business Overview
  52. 7.9.3 AbbVie Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 AbbVie Brain and Central Nervous System Cancer Treatments Product Portfolio
  54. 7.9.5 AbbVie Recent Developments
  55. 7.10 Takeda
  56. 7.10.1 Takeda Company Information
  57. 7.10.2 Takeda Business Overview
  58. 7.10.3 Takeda Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Takeda Brain and Central Nervous System Cancer Treatments Product Portfolio
  60. 7.10.5 Takeda Recent Developments
  61. 7.11 Otsuka
  62. 7.11.1 Otsuka Company Information
  63. 7.11.2 Otsuka Business Overview
  64. 7.11.3 Otsuka Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Otsuka Brain and Central Nervous System Cancer Treatments Product Portfolio
  66. 7.11.5 Otsuka Recent Developments
  67. 7.12 Merck KGaA
  68. 7.12.1 Merck KGaA Company Information
  69. 7.12.2 Merck KGaA Business Overview
  70. 7.12.3 Merck KGaA Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Merck KGaA Brain and Central Nervous System Cancer Treatments Product Portfolio
  72. 7.12.5 Merck KGaA Recent Developments
  73. 7.13 Ipsen
  74. 7.13.1 Ipsen Company Information
  75. 7.13.2 Ipsen Business Overview
  76. 7.13.3 Ipsen Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Ipsen Brain and Central Nervous System Cancer Treatments Product Portfolio
  78. 7.13.5 Ipsen Recent Developments
  79. 7.14 Gilead Sciences
  80. 7.14.1 Gilead Sciences Company Information
  81. 7.14.2 Gilead Sciences Business Overview
  82. 7.14.3 Gilead Sciences Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Gilead Sciences Brain and Central Nervous System Cancer Treatments Product Portfolio
  84. 7.14.5 Gilead Sciences Recent Developments
  85. 7.15 Eli Lilly
  86. 7.15.1 Eli Lilly Company Information
  87. 7.15.2 Eli Lilly Business Overview
  88. 7.15.3 Eli Lilly Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Eli Lilly Brain and Central Nervous System Cancer Treatments Product Portfolio
  90. 7.15.5 Eli Lilly Recent Developments
  91. 7.16 Eisai
  92. 7.16.1 Eisai Company Information
  93. 7.16.2 Eisai Business Overview
  94. 7.16.3 Eisai Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Eisai Brain and Central Nervous System Cancer Treatments Product Portfolio
  96. 7.16.5 Eisai Recent Developments
  97. 7.17 Celgene
  98. 7.17.1 Celgene Company Information
  99. 7.17.2 Celgene Business Overview
  100. 7.17.3 Celgene Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Celgene Brain and Central Nervous System Cancer Treatments Product Portfolio
  102. 7.17.5 Celgene Recent Developments
  103. 7.18 Bristol-Myers Squibb
  104. 7.18.1 Bristol-Myers Squibb Company Information
  105. 7.18.2 Bristol-Myers Squibb Business Overview
  106. 7.18.3 Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Product Portfolio
  108. 7.18.5 Bristol-Myers Squibb Recent Developments
  109. 7.19 Biogen Idec
  110. 7.19.1 Biogen Idec Company Information
  111. 7.19.2 Biogen Idec Business Overview
  112. 7.19.3 Biogen Idec Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Biogen Idec Brain and Central Nervous System Cancer Treatments Product Portfolio
  114. 7.19.5 Biogen Idec Recent Developments
  115. 7.20 AstraZeneca
  116. 7.20.1 AstraZeneca Company Information
  117. 7.20.2 AstraZeneca Business Overview
  118. 7.20.3 AstraZeneca Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 AstraZeneca Brain and Central Nervous System Cancer Treatments Product Portfolio
  120. 7.20.5 AstraZeneca Recent Developments
  121. 7.21 Astellas
  122. 7.21.1 Astellas Company Information
  123. 7.21.2 Astellas Business Overview
  124. 7.21.3 Astellas Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Astellas Brain and Central Nervous System Cancer Treatments Product Portfolio
  126. 7.21.5 Astellas Recent Developments
  127. 7.22 Amgen
  128. 7.22.1 Amgen Company Information
  129. 7.22.2 Amgen Business Overview
  130. 7.22.3 Amgen Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Amgen Brain and Central Nervous System Cancer Treatments Product Portfolio
  132. 7.22.5 Amgen Recent Developments
8 North America
  1. 8.1 North America Brain and Central Nervous System Cancer Treatments Market Size by Type
  2. 8.1.1 North America Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2032)
  3. 8.1.2 North America Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2032)
  4. 8.1.3 North America Brain and Central Nervous System Cancer Treatments Price by Type (2021-2032)
  5. 8.2 North America Brain and Central Nervous System Cancer Treatments Market Size by Application
  6. 8.2.1 North America Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2032)
  7. 8.2.2 North America Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2032)
  8. 8.2.3 North America Brain and Central Nervous System Cancer Treatments Price by Application (2021-2032)
  9. 8.3 North America Brain and Central Nervous System Cancer Treatments Market Size by Country
  10. 8.3.1 North America Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Brain and Central Nervous System Cancer Treatments Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Brain and Central Nervous System Cancer Treatments Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Brain and Central Nervous System Cancer Treatments Market Size by Type
  2. 9.1.1 Europe Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2032)
  3. 9.1.2 Europe Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2032)
  4. 9.1.3 Europe Brain and Central Nervous System Cancer Treatments Price by Type (2021-2032)
  5. 9.2 Europe Brain and Central Nervous System Cancer Treatments Market Size by Application
  6. 9.2.1 Europe Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2032)
  7. 9.2.2 Europe Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2032)
  8. 9.2.3 Europe Brain and Central Nervous System Cancer Treatments Price by Application (2021-2032)
  9. 9.3 Europe Brain and Central Nervous System Cancer Treatments Market Size by Country
  10. 9.3.1 Europe Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Brain and Central Nervous System Cancer Treatments Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Brain and Central Nervous System Cancer Treatments Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Brain and Central Nervous System Cancer Treatments Market Size by Type
  2. 10.1.1 China Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2032)
  3. 10.1.2 China Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2032)
  4. 10.1.3 China Brain and Central Nervous System Cancer Treatments Price by Type (2021-2032)
  5. 10.2 China Brain and Central Nervous System Cancer Treatments Market Size by Application
  6. 10.2.1 China Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2032)
  7. 10.2.2 China Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2032)
  8. 10.2.3 China Brain and Central Nervous System Cancer Treatments Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Brain and Central Nervous System Cancer Treatments Market Size by Type
  2. 11.1.1 Asia Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2032)
  3. 11.1.2 Asia Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2032)
  4. 11.1.3 Asia Brain and Central Nervous System Cancer Treatments Price by Type (2021-2032)
  5. 11.2 Asia Brain and Central Nervous System Cancer Treatments Market Size by Application
  6. 11.2.1 Asia Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2032)
  7. 11.2.2 Asia Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2032)
  8. 11.2.3 Asia Brain and Central Nervous System Cancer Treatments Price by Application (2021-2032)
  9. 11.3 Asia Brain and Central Nervous System Cancer Treatments Market Size by Country
  10. 11.3.1 Asia Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Brain and Central Nervous System Cancer Treatments Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Brain and Central Nervous System Cancer Treatments Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Brain and Central Nervous System Cancer Treatments Market Size by Type
  2. 12.1.1 SAMEA Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Brain and Central Nervous System Cancer Treatments Price by Type (2021-2032)
  5. 12.2 SAMEA Brain and Central Nervous System Cancer Treatments Market Size by Application
  6. 12.2.1 SAMEA Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Brain and Central Nervous System Cancer Treatments Price by Application (2021-2032)
  9. 12.3 SAMEA Brain and Central Nervous System Cancer Treatments Market Size by Country
  10. 12.3.1 SAMEA Brain and Central Nervous System Cancer Treatments Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Brain and Central Nervous System Cancer Treatments Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Brain and Central Nervous System Cancer Treatments Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Brain and Central Nervous System Cancer Treatments Value Chain Analysis
  2. 13.1.1 Brain and Central Nervous System Cancer Treatments Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Brain and Central Nervous System Cancer Treatments Production Mode & Process
  6. 13.2 Brain and Central Nervous System Cancer Treatments Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Brain and Central Nervous System Cancer Treatments Distributors
  9. 13.2.3 Brain and Central Nervous System Cancer Treatments Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst